1 The Intestinal Barrier: A Key Player in Chronic Illness
Without enough of it, your body starts making red blood cells that are too large and structurally abnormal a condition called megaloblastic anemia
Your PlexusDx provider monitors thyroid markers and other safety indicators throughout treatment
Beneficiaries need to meet at least one of the following, based on their BMI and health history when they first started GLP-1 therapy: A BMI of 35 or higher A BMI of 30 or higher, with a history of heart failure, uncontrolled hypertension, or chronic kidney disease A BMI of 27 or higher, with prediabetes, a previous heart attack or stroke, or symptomatic peripheral artery disease Beneficiaries who already have GLP-1 coverage under Part D for a separate condition, such as type 2 diabetes or sleep apnea, arent eligible for the Bridge
Lpez-Otn C, Blasco MA, Partridge L, et al